ConductScience.org, home

Paper36970507

Podoplanin: A potential therapeutic target for thrombotic diseases.

Huang Y and 5 others. Front Neurol, 2023. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Podoplanin: A potential therapeutic target for thrombotic diseases. Papers, record 36970507. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36970507

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Podoplanin: A potential therapeutic target for thrombotic diseases.
PubMed
Journal
Front Neurol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.9
iCite
Revised in PubMed
2024-09-14
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Huang YYaqian
2Lu MManli
3Wang YYi
4Zhang CChunyuan
5Cao YYongjun
6Zhang XXia

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References101

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130522766Activation of fibroblastic reticular cells in kidney lymph node during crescentic glomerulonephritis.Kidney Int2019https://conductscience.org/library/papers/30522766PubMed
232048302Platelet regulates neuroinflammation and restores blood-brain barrier integrity in a mouse model of traumatic brain injury.J Neurochem2020https://conductscience.org/library/papers/32048302PubMed
39327748Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis.Am J Pathol1997https://conductscience.org/library/papers/9327748PubMed
433548843Blocking podoplanin inhibits platelet activation and decreases cancer-associated venous thrombosis.Thromb Res2021https://conductscience.org/library/papers/33548843PubMed
529676036Combination of isocitrate dehydrogenase 1 (IDH1) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolism.J Thromb Haemost2018https://conductscience.org/library/papers/29676036PubMed
632208352Wild-Type IDH1 and Mutant IDH1 Opposingly Regulate Podoplanin Expression in Glioma.Transl Oncol2020https://conductscience.org/library/papers/32208352PubMed
734568969Role of podoplanin and Kupffer cells in liver injury after ischemia-reperfusion in mice.Surg Today2022https://conductscience.org/library/papers/34568969PubMed
834163489CLEC-2 Prevents Accumulation and Retention of Inflammatory Macrophages During Murine Peritonitis.Front Immunol2021https://conductscience.org/library/papers/34163489PubMed
917222411Functional glycosylation of human podoplanin: glycan structure of platelet aggregation-inducing factor.FEBS Lett2007https://conductscience.org/library/papers/17222411PubMed
1031778548Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin.Blood2019https://conductscience.org/library/papers/31778548PubMed
1117944973Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2.Cancer Sci2008https://conductscience.org/library/papers/17944973PubMed
1223548777Effects of everolimus on oxidative stress in kidney model of ischemia/reperfusion injury.Am J Nephrol2013https://conductscience.org/library/papers/23548777PubMed
1315515019Characterization of human PA2.26 antigen (T1alpha-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas.Int J Cancer2005https://conductscience.org/library/papers/15515019PubMed
149744646Tumor necrosis factor up-regulates intercellular adhesion molecule 1, which is important in the neutrophil-dependent lung and liver injury associated with hepatic ischemia and reperfusion in the rat.Shock1998https://conductscience.org/library/papers/9744646PubMed
1530580704Prognostic Significance of Plasma CLEC-2 (C-Type Lectin-Like Receptor 2) in Patients With Acute Ischemic Stroke.Stroke2019https://conductscience.org/library/papers/30580704PubMed
1634608736Podoplanin promotes tumor growth, platelet aggregation, and venous thrombosis in murine models of ovarian cancer.J Thromb Haemost2022https://conductscience.org/library/papers/34608736PubMed
1732441651Podoplanin promotes cancer-associated thrombosis and contributes to the unfavorable overall survival in an ectopic xenograft mouse model of oral cancer.Biomed J2020https://conductscience.org/library/papers/32441651PubMed
1825458834A platform of C-type lectin-like receptor CLEC-2 for binding O-glycosylated podoplanin and nonglycosylated rhodocytin.Structure2014https://conductscience.org/library/papers/25458834PubMed
1926031780Nutrition and Atherosclerosis.Arch Med Res2015https://conductscience.org/library/papers/26031780PubMed
2031391335High-dimensional analysis reveals a pathogenic role of inflammatory monocytes in experimental diffuse alveolar hemorrhage.JCI Insight2019https://conductscience.org/library/papers/31391335PubMed

See all 101 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42583349Podoplanin-positive extracellular vesicles in ovarian cancer: linking thrombosis, platelet crosstalk, and cancer stemness - a narrative review.Ann Med Surg (Lond)2026https://conductscience.org/library/papers/42583349PubMed
41835213Emerging roles of haemostatic proteins as markers of disease progression and prognosis in breast cancer.Explor Target Antitumor Ther2026https://conductscience.org/library/papers/41835213PubMed
41465476Does Podoplanin (PDPN) Reflect the Involvement of the Immunological System in Coronary Artery Disease Risk? A Single-Center Prospective Analysis.Int J Mol Sci2025https://conductscience.org/library/papers/41465476PubMed
40809467Mechanisms of Cancer Cell Lymphatic Endothelialization in Tumor Lymphangiogenesis and Metastasis: A Comprehensive Review.J Inflamm Res2025https://conductscience.org/library/papers/40809467PubMed
38391918Interaction between NSCLC Cells, CD8+ T-Cells and Immune Checkpoint Inhibitors Potentiates Coagulation and Promotes Metabolic Remodeling-New Cues on CAT-VTE.Cells2024https://conductscience.org/library/papers/38391918PubMed

Download CSV of cited by

Genes14

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36970507

GET https://conductscience.org/api/papers/v1/36970507/references?page=2